Delivery Order SPE2DB24D9314-SPE2DB25FKRMB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 11, 2025, with an ultimate completion date of October 2, 2025. This delivery order is issued under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 19, 2025, for Mirena 52 mg systems, with an ultimate completion date of October 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an unrestricted...
- The Defense Logistics Agency awarded a $3,124.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with a completion date of August 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order at its Park Ridge facility. This delivery order was issued without set-aside designation, leveraging the company's competitive positioning in federal pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is set for ultimate completion by August 12, 2025, and represents a discrete purchase under the company's existing relationship with the DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor and will fulfill this order directly...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $20,830.80 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order represents no set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a delivery order valued at $29,163.12 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation on July 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, Illinois. This delivery order...
- The Defense Logistics Agency awarded a $3,124.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 28, 2025. This delivery order, issued on August 7, 2025, carries no set-aside designation and will be fulfilled from DMS Pharmaceutical Group's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has been registered in the System for Award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its primary location. The company has been registered in the System for Award...
- SPE2DB24D9314Indefinite Delivery Contract
- SPE2DB24D9314-SPE2DB25FKRMBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, made on August 14, 2025, with an ultimate completion date of September 5, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor for this delivery order. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The parent contract, executed under the SPE2DB program, establishes the framework for the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. As a woman-owned small business, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription medications, biologics, and medical consumables for military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/14/25 |